🔎 Trials Near Me

Beranda › Hemofilia › Indiana

Uji klinis Hemofilia di Indiana

9 studi untuk Hemofilia mencari peserta di lokasi di Indiana.

Kota di Indiana

Teks studi resmi (Bahasa Inggris)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • Innovative Hematology, Inc., Indianapolis
Menerima pesertaFase 3
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT05568719

A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

  • Indiana Hemophilia-Thromb Ctr, Indianapolis
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 64 · Pria · Diperbarui 18 Sep 2026 · NCT07220564

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

  • Indiana Hemophilia & Thrombosis center, Indianapolis
Menerima pesertaFase 1/2
Usia 2 hingga 59 · Pria · Diperbarui 11 Sep 2026 · NCT05987449

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  • Innovative Hematology, Inc., Indianapolis
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07416604

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Indiana Hemophilia and Thrombosis Center, Indianapolis
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

  • Indiana Hemophilia & Thrombosis Center, Indianapolis
Menerima pesertaStudi observasional
Usia 6 hingga 19 · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT05022459

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

  • Innovative Hematology, Inc. (IHI), Indianapolis
Menerima pesertaFase 1
Usia 0 hingga 90 · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT05500807

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

  • Innovative Hematology, Inc.- Site Number : 8400006, Indianapolis
Menerima pesertaFase 4
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 18 Nov 2025 · NCT06941870

Hemlibra in Mild Hemophilia A

  • Indiana Hemophila @Thrombosis Center, Indianapolis
Menerima pesertaFase 4
Usia 5 hingga 45 · Pria · Diperbarui 15 Mar 2024 · NCT04567511

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.